42 Providing application programs for smartphones, personal digital assistants and computer hardware for the purpose of treatments of diseases (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); providing application programs for smartphones, personal digital assistants and computer hardware for the purpose of improving efficiencies of clinical trials (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); providing application programs for smartphones, personal digital assistants and computer hardware for the purpose of development and research on medicines and medical devices (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); providing application programs for smartphones, personal digital assistants and computer hardware for the purpose of analyzing medical data with artificial intelligence (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); designing, developing, programming or maintenance of computer programs and software for smartphones, personal digital assistants and computer hardware for the purpose of treatments of diseases; designing, developing, programming or maintenance of computer programs and software for smartphones, personal digital assistants and computer hardware for the purpose of improving efficiencies of clinical trials; designing, developing, programming or maintenance of computer programs and software for smartphones, personal digital assistants and computer hardware for the purpose of development and research on medicines and medical devices; designing, developing, programming or maintenance of computer programs and software for smartphones, personal digital assistants and computer hardware for the purpose of analyzing medical data with artificial intelligence; designing, developing, or maintenance of websites; consulting services on development and research of medical equipment; planning and drafting of clinical trials; evaluation and inspection on results of clinical trials